Human Genome Epidemiology Literature Finder
Records 1 - 14 (of 14 Records) |
Query Trace: Hypertension and TP53[original query] |
---|
[Association of gene TP53 polymorphic marker Pro72Arg with clinical characteristics of chronic glomerulonephritis]. Terapevticheski? arkhiv 2011 83 (6): 27-32. Kamyshova E S, Shvetsov M Iu, Shestakov A E, Kutyrina I M, Nosikov V |
Polymorphisms of codon 72 of the TP53 gene in endometrial carcinoma of postmenopausal women. Post?py higieny i medycyny do?wiadczalnej (Online) 2013 67 (0): 1312-8. Zaj?c Agnieszka, Stachowiak Grzegorz, Smolarz Beata, Wilczy?ski Jacek |
Phase I study of pazopanib and vorinostat: a therapeutic approach for inhibiting mutant p53-mediated angiogenesis and facilitating mutant p53 degradation. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 May 26 (5): 1012-8. Fu S, Hou M M, Naing A, Janku F, Hess K, Zinner R, Subbiah V, Hong D, Wheler J, Piha-Paul S, Tsimberidou A, Karp D, Araujo D, Kee B, Hwu P, Wolff R, Kurzrock R, Meric-Bernstam |
Familial aggregation of albuminuria and arterial hypertension in an Aboriginal Australian community and the contribution of variants in ACE and TP53. BMC nephrology 2016 Nov 17 (1): 183. Duffy David L, McDonald Stephen P, Hayhurst Beverley, Panagiotopoulos Sianna, Smith Trudy J, Wang Xing L, Wilcken David E, Duarte Natalia L, Mathews John, Hoy Wendy |
A Clinical and Molecular Phase II Trial of Oral ENMD-2076 in Ovarian Clear Cell Carcinoma (OCCC): A Study of the Princess Margaret Phase II Consortium. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Aug . Lheureux Stephanie, Tinker Anna, Clarke Blaise, Ghatage Prafull, Welch Stephen, Weberpals Johanne I, Dhani Neesha C, Butler Marcus O, Tonkin Katia, Tan Qian, Tan David S P, Brooks Kelly, Ramsahai Janelle, Wang Lisa, Pham Nhu-An, Shaw Patricia A, Tsao Ming S, Garg Swati, Stockley Tracey, Oza Amit |
Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 6 24 (19): 4650-4661. Lim Ho Yeong, Merle Philippe, Weiss Karl Heinz, Yau Thomas, Ross Paul, Mazzaferro Vincenzo, Blanc Jean-Frédéric, Ma Yuk Ting, Yen Chia Jui, Kocsis Judit, Choo Su Pin, Sukeepaisarnjaroen Wattana, Gérolami René, Dufour Jean-François, Gane Edward J, Ryoo Baek-Yeol, Peck-Radosavljevic Markus, Dao Thong, Yeo Winnie, Lamlertthon Wisut, Thongsawat Satawat, Teufel Michael, Roth Katrin, Reis Diego, Childs Barrett H, Krissel Heiko, Llovet Josep |
Genetic Profiling of Breast Cancer with and Without Preexisting Metabolic Disease. Translational oncology 2019 12 13 (2): 245-253. Jing Wenjiang, Li Ling, Zhang Xiumei, Wu Shouxin, Zhao Jiangman, Hou Qunxing, Wu Haotian, Ma Wu, Li Shuheng, Liu Huimin, Yang Binh |
Analysis of polymorphisms, promoter methylation, and mRNA expression profile of maternal and placental P53 and P21 genes in preeclamptic and normotensive pregnant women. Journal of biomedical science 2019 Nov 26 (1): 92. Harati-Sadegh Mahdiyeh, Kohan Leila, Teimoori Batool, Mehrabani Mehrnaz, Salimi Saeed |
Association of TP53 Mutations with Response to Anlotinib Treatment in Advanced Non-Small Cell Lung Cancer. OncoTargets and therapy 2020 8 13 6645-6650. Fang Shencun, Cheng Wanwan, Zhang Meiling, Yang Ruso |
Efficacy and Safety of Combination Treatment With Apatinib and Osimertinib After Osimertinib Resistance in Epidermal Growth Factor Receptor-Mutant Non-small Cell Lung Carcinoma-A Retrospective Analysis of a Multicenter Clinical Study. Frontiers in molecular biosciences 2021 5 8 639892. Yang Xue, Xia Yang, Xu Liyan, Liang Li, Zhuo Minglei, Wu Meina, An Tongtong, Wang Ziping, Wang Yuyan, Li Jianjie, Zhong Jia, Chen Hanxiao, Jia Bo, Wang Jingjing, Zhao J |
Associations of TP53 codon 72 polymorphism with complications and comorbidities in patients with type 1 diabetes. Journal of molecular medicine (Berlin, Germany) 2021 Jan . S?omi?ski Bartosz, Skrzypkowska Maria, Ryba-Stanis?awowska Monika, My?liwiec Ma?gorzata, Trzonkowski Pio |
Clinical features and next-generation sequencing landscape of essential thrombocythemia, prefibrotic primary myelofibrosis, and overt fibrotic primary myelofibrosis: a Chinese monocentric retrospective study. Journal of cancer research and clinical oncology 2022 6 . Zhang Lan, Ye Xingnong, Luo Shuna, Xu Xiaofei, Wang Shengjie, Jin Keyi, Zheng Yan, Zhu Xiaoqiong, Chen Dan, Jin Jie, Huang Ji |
Anlotinib in patients with recurrent platinum resistant/refractory ovarian cancer: a prospective, single arm, phase II study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2023 9 . Wenbin Shen, Chuyu Jing, Wenjuan Tian, Wei Zhang, Yulan Ren, Boer Shan, Huaying Wa |
Efficacy and safety analysis of anlotinib combined with PD-1 inhibitors in advanced non-small cell lung cancer: a retrospective cohort study. Journal of thoracic disease 2023 5 15 (4): 2003-2011. Xuanting Ye, Aimi Huang, Yan Zhou, Yanbin Kuang, Weimin Wang, Aiqin Gu, Ling |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: